当前位置： SCI文献检索 > Asia-Pacific Journal of Clinical Oncology期刊下所有文献 > Treatment and outcomes of melanoma in Asia: Results from the National Cancer Centre Singapore.

Treatment and outcomes of melanoma in Asia: Results from the National Cancer Centre Singapore.

Abstract：

BACKGROUND:Acral melanoma (AM) and mucosal melanoma (MM) make up more than half of melanomas in Asia but comprise only 5% of cases in Caucasians, where cutaneous melanoma (CM) predominates. AM and MM are thought to be genetically and biologically distinct from CM. We report the characteristics and outcomes of melanoma patients from the National Cancer Centre Singapore. METHODS:Case records of 210 patients treated between 2002 and 2014 were reviewed. RESULTS:Median follow-up was 2.5 years. CM, AM and MM made up of 37.6%, 33.8% and 16.2% of cases, respectively, with 6.2% each having ocular melanoma and unknown primary. Caucasians made up 16.2% of patients, accounting for 36.7% of CM but only 2.8 of AM and 2.9% of MM. Patients with MM (2.9% stage I, 14.7% stage IV) presented with higher American Joint Committee on Cancer (AJCC) stage than those with AM (16.9% stage I, 5.6% stage IV) or CM (24.1% stage I, 8.9% stage IV) (P = 0.01). Median overall survival (OS) was 5.7 years for all patients, and 1.0 year for metastatic disease. Considering stage I-III disease, multivariable Cox regression analysis demonstrated age ≥60 years and higher stage to be independent adverse prognostic factors for RFS and OS. Sentinel lymph node biopsy, undertaken for 56 stage I-III patients (25 AM, 31 CM) did not influence outcome. CONCLUSION:Our study reinforces the known unique clinicopathologic features of melanomas in Asians where AM and MM predominate. Age and stage remain the most critical prognostic factors across all subtypes.

journal_name

Asia Pac J Clin Oncol

journal_title

Asia-Pacific journal of clinical oncology

authors

Teh YL,Goh WL,Tan SH,Yong G,Sairi ANH,Soo KC,Ong J,Chia C,Tan G,Soeharno H,Tan MH,Chan M,Sathiyamoorthy S,Sittampalam K,Teh J,Chin F,Sethi V,Teo M,Quek R,Farid M

doi

10.1111/ajco.12802

subject

Has Abstract

pub_date

2018-04-01 00:00:00

pages

e95-e102

issue

2

eissn

1743-7555

issn

1743-7563

journal_volume

14

pub_type

杂志文章

相关文献

Asia-Pacific Journal of Clinical Oncology文献大全
  • Pathological outcomes in rectal cancer following laparoscopic surgery.

    abstract：AIM:This study examined pathological quality-of-surgery indicators in laparoscopic and open rectal cancer resection specimens. METHODS:Retrospective analysis of consecutive, prospectively recorded laparoscopic (LR) or open (OR) resections for rectal cancer. Indicators included integrity of the perirectal fascial envel...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12781

    authors： Cheung HYC,Dent OF,Richardson GL,Chan C,Keshava A,Young CJ

    更新日期：2018-04-01 00:00:00

  • Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes.

    abstract：AIM:Clinical and pharmacokinetic effects of azacitidine in higher-risk myelodysplastic syndromes were established in mainly Caucasian populations. Because of inter-ethnic genotype variability of drug-metabolizing enzymes, it is important to evaluate azacitidine in populations expected to use the drug. METHODS:In this ...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12659

    authors： Chou WC,Yeh SP,Hsiao LT,Lin SF,Chen YC,Chen TY,Laille E,Galettis A,Dong Q,Songer S,Beach CL

    更新日期：2017-10-01 00:00:00

  • Insights into the cell of origin in breast cancer and breast cancer stem cells.

    abstract：:The precise cell types that give rise to tumors and mechanisms that underpin tumor heterogeneity are poorly understood. There is increasing evidence to suggest that diverse solid tumors are hierarchically organized and may be sustained by a distinct subpopulation of cancer stem cells (CSCs). The CSC hypothesis provide...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1111/j.1743-7563.2010.01279.x

    authors： Lindeman GJ,Visvader JE

    更新日期：2010-06-01 00:00:00

  • Correlations between CD4+ FoxP3+ Treg and expression of FoxM1 and Ki-67 in gastric cancer patients.

    abstract：AIMS:In this study, we intended to analyze the clinical significance of CD4+ FoxP3+ Tregs in gastric cancer patients and investigate the relationship between the proportion of CD4+ FoxP3+ Tregs in the peripheral blood and the expression of FoxM1 and Ki-67 in gastric cancer tissues. METHODS:Flow cytometry was used to m...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13302

    authors： Ma K,Li X,Lv J,Liu Z,Zhang L,Cong H,Wang H,Shen F,Yue L

    更新日期：2020-01-19 00:00:00

  • Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer.

    abstract：AIM:To evaluate tumor markers as prognostic factors in patients with metastatic or recurrent gastric cancer receiving first-line chemotherapy. METHODS:Between January 2000 and December 2008, 1178 patients with metastatic or recurrent gastric cancer were assayed for expression of three serum tumor markers, CA 19-9, CA ...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12019

    authors： Jo JC,Ryu MH,Koo DH,Ryoo BY,Kim HJ,Kim TW,Choi KD,Lee GH,Jung HY,Yook JH,Oh ST,Kim BS,Kim JH,Kang YK

    更新日期：2013-12-01 00:00:00

  • Salvage stereotactic body radiotherapy for locally recurrent uterine cervix cancer at the pelvic sidewall: Feasibility and complication.

    abstract：AIMS:To determine the feasibility of stereotactic body radiotherapy (SBRT) in patients with pelvic sidewall recurrence of uterine cervical cancer after radical hysterectomy or definitive radiotherapy. METHODS:We retrospectively reviewed 23 patients with locally recurrent uterine cervical cancer limited to the pelvic s...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12185

    authors： Seo Y,Kim MS,Yoo HJ,Jang WI,Rhu SY,Choi SC,Kim MH,Kim BJ,Lee DH,Cho CK

    更新日期：2016-06-01 00:00:00

  • Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm.

    abstract：:Resistance to endocrine therapy is a significant therapeutic challenge in the treatment of women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer. Cyclin-dependent kinase (CDK)4/6 inhibitors in combination with endocrine therapy have been shown to i...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13064

    authors： Boyle F,Beith J,Burslem K,de Boer R,Hui R,Lim E,McCarthy N,Redfern A,Woodward N

    更新日期：2018-10-01 00:00:00

  • An exploration of the dynamics and influences upon second medical opinion consultations in cancer care.

    abstract：AIM:The aim of this study was to explore the dynamics within second medical opinion consultations in patients with cancer. METHODS:Semi-structured interviews were held with four oncologists and were subjected to a thematic analysis to define the broad issues. These formed the basis of a survey distributed to Australia...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/j.1743-7563.2010.01330.x

    authors： Philip J,Gold M,Schwarz M,Komesaroff P

    更新日期：2011-03-01 00:00:00

  • Immunotherapy for urothelial carcinoma: Metastatic disease and beyond.

    abstract：:For advanced and metastatic urothelial carcinomas (UCs), platinum (preferably cisplatin)-based chemotherapy has been the standard treatment for many years. However, many patients are ineligible for cisplatin-based chemotherapy because of poor performance status and/or other age-related conditions. At the other end of ...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1111/ajco.13312

    authors： Poon DM

    更新日期：2020-09-01 00:00:00

  • Potential issues with complementary medicines commonly used in the cancer population: A retrospective review of a tertiary cancer center's experience.

    abstract：AIM:Complementary medicine (CAM) use in the cancer population is higher than the general population: some studies estimate up to 70%. Our Medicines Information Centre, in a tertiary cancer institution, receives many enquiries regarding use and safety of CAM with conventional cancer therapies (chemotherapy, radiotherapy...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13026

    authors： Brooks SL,Rowan G,Michael M

    更新日期：2018-10-01 00:00:00

  • International survey of awareness of genetic risk in the clinical sarcoma community.

    abstract：AIM:Integration of clinical genetics into oncology is variable. Sarcomas have a strong genetic component, with up to 1/30 patients carrying germline TP53 mutations. This study aimed to define genetic risk awareness among sarcoma physicians. Outcomes were attitudes toward genetic testing, level of cancer risk and awaren...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12457

    authors： McBride KA,Schlub TE,Ballinger ML,Thomas DM,Tattersall MH

    更新日期：2016-06-01 00:00:00

  • Oral cyclophosphamide in recurrent ovarian cancer.

    abstract：AIMS:Cyclophosphamide was widely used as a single agent prior to the advent of platinum-based regimens for epithelial ovarian cancer, and, in combination with platinum, prior to the adoption of platinum and paclitaxel as standard first-line therapy. As cyclophosphamide currently has no defined role in ovarian cancer we...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12074

    authors： Handolias D,Quinn M,Foo S,Mileshkin L,Grant P,Dutu G,Rischin D

    更新日期：2016-03-01 00:00:00

  • Afatinib for an EGFR exon 20 insertion mutation: A case report of progressive stage IV metastatic lung adenocarcinoma with 54 months' survival.

    abstract：:Non-small cell lung cancers (NSCLC) harboring the uncommon epidermal growth factor receptor (EGFR) exon 20 insertion mutations are generally thought to be unresponsive to EGFR-tyrosine kinase inhibitor (TKI) therapy. Presented here is a case of stage IV NSCLC harboring an uncommon EGFR exon 20 insertion mutation that ...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12853

    authors： Chan RT

    更新日期：2018-03-01 00:00:00

  • Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival.

    abstract：BACKGROUND:Metastatic colorectal cancer (mCRC) patients with a right-sided primary (RC) have an inferior survival to mCRC arising from a left-sided primary (LC). Previous analyses have suggested multiple factors contribute. METHODS:The Treatment of Recurrent and Advanced Colorectal Cancer (TRACC) Registry prospectivel...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13135

    authors： Mendis S,Beck S,Lee B,Lee M,Wong R,Kosmider S,Shapiro J,Yip D,Steel S,Nott L,Jennens R,Lipton L,Burge M,Field K,Ananda S,Wong HL,Gibbs P

    更新日期：2019-06-01 00:00:00

  • Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose-reduced 3-weekly docetaxel for metastatic castration-resistant prostate cancer.

    abstract：BACKGROUND:Docetaxel is an effective therapy for metastatic castration-resistant prostate cancer (mCRPC); however, many patients experience febrile neutropenia (FN) and cease treatment early due to toxicity. It is not known whether lower dose (LD) q3-weekly docetaxel impacts toxicity or efficacy. METHODS:Multicenter r...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1111/ajco.12840

    authors： Hamid AA,Willson K,Vincent AD,Tamjid B,Lee M,Bergin A,Gan C,Campbell A,Stewart J,Pezaro C,Tran B,Weickhardt AJ

    更新日期：2018-10-01 00:00:00

  • Association of plasma visfatin with risk of colorectal cancer: An observational study of Chinese patients.

    abstract：AIM:To investigate the association between plasma visfatin levels and risk of early and advanced colorectal cancer (CRC). METHODS:In total, 358 CRC patients and 286 controls were enrolled. According to the T factor of the TNM system. cancer patients were divided into two subgroups: early and advanced cancer. Levels of...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12090

    authors： Chen M,Wang Y,Li Y,Zhao L,Ye S,Wang S,Yu C,Xie H

    更新日期：2016-03-01 00:00:00

  • Impact of modified FOLFOX-6 for patients with gastric cancer and a gastrointestinal obstruction.

    abstract：AIM:Gastric cancer patients are normally treated with oral fluoropyrimidine and cisplatin or oxaliplatin; however, treating patients who also have a gastrointestinal obstruction is often difficult because of their poor oral intake. Instead, a modified (m)FOLFOX-6 regimen is administered, even to patients with gastroint...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13110

    authors： Yukami H,Terazawa T,Goto M,Aoki M,Asaishi K,Yamaguchi T,Kuwakado S,Kii T,Higuchi K

    更新日期：2019-10-01 00:00:00

  • Endoscopic self-expandable metallic stent placement in malignant pyloric or duodenal obstruction: does chemotherapy affect stent patency?

    abstract：AIM:Self-expandable metallic stents (SEMS) have been used for palliation in patients with malignant gastroduodenal obstructions. We evaluated clinical outcomes after SEMS placement and identified prognostic factors of SEMS patency, including chemotherapy. METHODS:A review of records of 85 patients with unresectable ga...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/j.1743-7563.2012.01590.x

    authors： Cha BH,Lee SH,Kim JE,Yoo JY,Park YS,Kim JW,Jeong SH,Kim N,Lee DH,Hwang JH

    更新日期：2013-06-01 00:00:00

  • Importance of health literacy in oncology.

    abstract：:Health literacy refers to one's ability to obtain, process and understand health information and services to enable sound health decision-making. This is an area of increasing importance due to the complexity of the health system, especially in the cancer setting. A certain level of health literacy is required for pat...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1111/j.1743-7563.2012.01522.x

    authors： Koay K,Schofield P,Jefford M

    更新日期：2012-03-01 00:00:00

  • End of life experiences of patients with advanced cancer in Myanmar: Results from the APPROACH study.

    abstract：BACKGROUND:Access to palliative care services is essential for attaining universal health coverage for patients with a terminal cancer. Despite this, many patients with advanced cancer in low-income countries, such as Myanmar, suffer at the end of life (EOL) due to little or no access to palliative care. However, actua...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1111/ajco.13373

    authors： Mon SW,Ozdemir S,Zu WWM,Win H,Maw MM,Win KC,Thant KZ,Teo I,Krishnan A,Goh CR,Finkelstein EA,Malhotra C

    更新日期：2020-12-01 00:00:00

  • Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer.

    abstract：BACKGROUND:Anti-HER2 therapy-related cardiotoxicity is well described in the context of clinical trials, particularly in the setting of early stage disease, but there is more limited data in advanced breast cancer and in the real world setting. MATERIAL AND METHODS:A prospectively-maintained registry database with 312...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.13381

    authors： Conduit C,de Boer RH,Lok S,Gibbs P,Malik L,Loh Z,Yeo B,Greenberg S,Devitt B,Lombard J,Nottage M,Collins I,Torres J,Nolan M,Nott L

    更新日期：2020-12-01 00:00:00

  • Effect of pre existing respiratory conditions on survival of lung cancer patients: A nationwide population-based cohort study.

    abstract：BACKGROUND:Common diseases with potential to increase the risk of death from lung cancer have so far not been studied in large populations. METHODS:We did a population-based retrospective cohort study using nationwide health insurance claims data from 2005 to 2012 in Korea including 205 403 lung cancer patients. Multi...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12697

    authors： Hong S,Park EC,Kim TH,Kwon JA,Yoo KB,Han KT,Yoo JW,Kim SJ

    更新日期：2018-04-01 00:00:00

  • Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients.

    abstract：AIM:For early-stage breast cancer, four cycles of docetaxel and cyclophosphamide (TC) was proven superior to doxorubicin plus cyclophosphamide in the US Oncology 9375 trial. Given primary prophylactic antibiotics, 5% febrile neutropenia was recorded in a population comprising 75.5% Caucasians. Smaller trials and retros...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12682

    authors： Chow LWC,Biganzoli L,Leo AD,Kuroi K,Han HS,Patel J,Huang CS,Lu YS,Zhu L,Chow CYC,Loo WTY,Glück S,Toi M

    更新日期：2017-12-01 00:00:00

  • Differentiating malignant colorectal tumor patients from benign colorectal tumor patients by assaying morning urinary arylsulfatase activity.

    abstract：AIM:For several decades urinary arylsulfatase (ARS) activity has been reported to be elevated in many cancers. It has been shown that urinary ARS activity may serve as a marker of tumor progression and therapy surveillance. This study was designed to evaluate the clinical application of detection of urinary ARS activit...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/j.1743-7563.2012.01545.x

    authors： Niu R,Jing H,Chen Z,Xu J,Dai J,Yan Z

    更新日期：2012-12-01 00:00:00

  • A mixed methods analysis of experiences and expectations among early-career medical oncologists in Australia.

    abstract：AIM:A viable and sustainable medical oncology profession is integral for meeting the increasing demand for quality cancer care. The aim of this study was to explore the workforce-related experiences, perceptions and career expectations of early-career medical oncologists in Australia. METHODS:A mixed-methods design, i...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12844

    authors： Wong WKT,Kirby E,Broom A,Sibbritt D,Francis K,Karapetis CS,Karikios D,Harrup R,Lwin Z

    更新日期：2018-10-01 00:00:00

  • Acute inflammatory demyelinating polyradiculoneuropathy in a patient receiving oxaliplatin-based chemotherapy.

    abstract：:We report a case of acute inflammatory demyelinating polyradiculoneuropathy (AIDP) that developed in a patient with cholangiocarcinoma after receiving oxaliplatin-based chemotherapy. A 62-year-old man had multiple hypodense lesions with delayed enhancement in the both lobes of the liver on abdominal computed tomograph...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/j.1743-7563.2011.01515.x

    authors： Yoon JY,Nam TS,Kim MK,Hwang JE,Shim HJ,Cho SH,Chung IJ,Bae WK

    更新日期：2012-06-01 00:00:00

  • Additional chemotherapy and salvage surgery for poor response to chemoradiotherapy in rectal cancers.

    abstract：AIM:A proportion of locally advanced rectal cancer patients who receive neoadjuvant chemoradiotherapy (NACRT) are still unresectable. This study was undertaken to assess the outcomes of giving additional chemotherapy to rectal cancer patients with unresectable disease after NACRT. METHODS:Patients with poor response t...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12660

    authors： Engineer R,Ostwal V,Arya S,Gupta P,Chopra S,Patil P,Jatal S,Saklani A

    更新日期：2017-08-01 00:00:00

  • Hospital morbidity data for determining spread of disease at diagnosis for colorectal cancer: a validation study.

    abstract：AIMS:There is currently no routine collection of cancer stages in population-based data in Australia. This study evaluates the accuracy of International classification of diseases (ICD) codes for secondary neoplasms recorded in hospital morbidity data to assign spread of disease at diagnosis for colorectal cancer. MET...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/j.1743-7563.2012.01537.x

    authors： Thompson B,Lumley J,Coory M

    更新日期：2012-09-01 00:00:00

  • Factors influencing medical oncology referral in Dukes' C colonic cancer.

    abstract：AIM:Colorectal cancer (CRC) is one of the most common malignancies worldwide and adjuvant chemotherapy is proven to improve survival in patients with Dukes' C CRC. The purpose of this study was to analyze factors influencing referral to medical oncology in patients with Dukes' C colonic cancer in our institutions. MET...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/j.1743-7563.2010.01312.x

    authors： Lu CT,Stephens JH,Rieger NA

    更新日期：2010-09-01 00:00:00

  • Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment.

    abstract：AIM:Elevated neutrophil-to-lymphocyte ratio (NLR) has been demonstrated to be a poor prognostic factor in multiple types of malignancies, whereas the effect of NLR on the prognosis of epidermal growth factor receptor (EGFR)-mutated advanced non-small-cell lung cancer (NSCLC) patients treated with first-line EGFR tyrosi...

    journal_title：Asia-Pacific journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1111/ajco.12273

    authors： Lin GN,Peng JW,Liu PP,Liu DY,Xiao JJ,Chen XQ

    更新日期：2017-10-01 00:00:00